When argenx, a global immunology company, encountered growing complexities in managing Trial Master File (TMF) migrations, they saw both a challenge and an opportunity. To address it, argenx partnered with NNIT to co-create a more efficient, scalable approach. The result was the eTMF Migration Factory, a solution built through collaboration to reduce manual effort and improve data consistency across CRO submissions.
Collaboration is a foundational principle for both NNIT and argenx. At argenx, it is embedded in their R&D model, where multidisciplinary teams - including scientists and antibody engineers - work together to advance immunology therapies. This spirit of collaboration, reflected in their guiding principle “together we discover”, also defined the joint development of the eTMF Migration Factory. The solution optimized TMF (Trial Master File) migration according to the specific requirements of argenx, but it also has applications beyond the project.